Home | Cardiovascular Business

While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.

Researchers explored data from five different randomized controlled trials, publishing their analysis in the American Journal of Cardiology.

Read more about PCI vs. CABG for left main disease: Key takeaways from a new meta-analysis

Abbott’s Aveir single-chamber (VR) leadless pacemaker FDA approval for treating patients with bradycardia. Image courtesy of Abbott.

Another single-chamber leadless pacemaker has officially hit the market.

Read more about Abbott’s single-chamber leadless pacemaker gains FDA approval

A snapshot from above at ACC.22.

Read our in-person coverage of the final day of ACC.22.

Read more about TAVR vs. surgery, FFR-guided PCI and DCB safety: Day 3 at ACC.22

A late-breaking study at ACC.22 showed differences in COVID-positive heart attack patients between 2020 and 2021. #ACC22 #ACC2022

A late-breaking study at ACC.22 showed differences in COVID-positive heart attack patients between 2020 and 2021. Cath lab photo by Jose Arellano, COVID image from NIH

New results from the North American COVID-19 STEMI (NACMI) registry showed a 25% reduction in early mortality in 2021 compared to 2020 among STEMI patients with a confirmed COVID-19 infection.

Read more about How the availability of vaccines impacted outcomes among STEMI patients with COVID-19

Steven E. Nissen, MD, discusses his late-breaking clinical trial with panelist Vera Bittner, MD, during day 2 of ACC.22.

Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time.

Read more about Cholesterol medications, flu shots and heart failure: Day 2 at ACC.22

ACC.22 kicked off on Saturday, April 2, in Washington, D.C.

A snapshot from the entry into ACC.22 in Washington, D.C.

Explore our on-the-ground coverage of the first day of ACC.22.

Read more about Salt restrictions, PCI breakthroughs and a social media primer for cardiologists: Day 1 at ACC.22

The new recommendations went live just ahead of ACC.22. They can be read in full in the Journal of the American College of Cardiology, Circulation or Journal of Cardiac Failure.

Read more about Cardiology groups debut new heart failure guidelines ahead of ACC.22

The new findings, based on data from nearly 500,000 patients, were presented during ACC.22.

Read more about Depression linked to a higher stroke risk among heart attack survivors

More than 6,000 IN.PACT Admiral Drug-Coated Balloons have been recalled, Medtronic announced Thursday.

The issue, identified during a routine inspection, appears to be related to a change in the manufacturing process. It has now been corrected, Medtronic said in a statement.

Read more about Medtronic recalls more than 6,000 catheters due to potential damage, loss of sterility

Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

The new analysis, published in the Journal of the American Heart Association, included patient data from the last three decades.

Read more about Eating avocados lowers CVD risk